Adrenocortical Carcinoma Treatment Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2017-2025
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Adrenocortical Carcinoma Treatment Market – Overview Adrenocortical carcinoma is a rare cancer affecting the outer layer of the adrenal glands, which are responsible for producing certain hormones and maintaining optimum blood pressure levels. Adrenocortical carcinoma is relatively frequent in children compared to other cancers, although the cancer may also affect adults. The most common symptoms of adrenocortical carcinoma include abdominal pain, hypertension, weight gain, and frequent urination, which are mainly caused due to tumors causing excess secretion of hormones from the adrenal glands. Mitotane is the only drug approved by the U.S. Food and Drug Administration (FDA) and European Medicine Executive Agency (EMEA) for treatment of metastatic adrenocortical carcinoma. According to the study by HealthLine Media, 2017, about 5-10% of the adrenal tumors are malignant. Diagnosis of adrenocortical carcinoma is based on urine tests, dexamethasone suppression test for detecting abnormal levels of cortisol, which is the hormone released by the adrenal glands. Also, a wide number of imaging devices are used for diagnoses of the disease, which includes CT scan, MRI, PET scan, and MIBG Scan, thus aiding for faster disease identification that aids the doctors to decide for further treatments.
Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Adrenocortical Carcinoma Treatment Market Taxonomy: On the basis of therapy type: ●
Chemotherapy
●
Targeted Therapy
●
Radiation Therapy
●
Adjuvant Therapy
On the basis of disease type: ●
Localized adrenocortical carcinoma
●
Metastatic adrenocortical carcinoma
Request for a sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/1551 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Adrenocortical Carcinoma Treatment Market: Key Players ●
ArQule, Inc.,
●
EnGeneIC Ltd.,
●
Exelixis, Inc.,
●
Merck & Co.,
●
Millendo Therapeutics, and
●
Orphagen Pharmaceuticals, Inc.
Manufactures are focused on launching novel therapeutic products for treatment of these rare diseases, thus accelerating market growth. For instance, in 2017, the FDA approved immunotherapy drug Keytruda (Pembrolizumab), the first anti-PD-1 (programmed death receptor-1) therapy, developed by Merck & Co., indicated for advanced adrenocortical carcinoma. View this report @ https://www.coherentmarketinsights.com/ongoing-insight/adrenocortical-carcinoma-treatment-market-1551 © Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS SECTOR COVERAGE Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY STUDIES
GLOBAL REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY ANALYSIS
CONSULT PROJECTS
SURVEY RESEARC H
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
To know more about us, visit our website: www.coherentmarketinsights.com
THANK YOU
Š Coherent market Insights. All Rights Reserved
For sales queries or new topics emailus on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702